Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?

Affiliations

¹ Luigi Sacco Department of Biomedical and Clinical Sciences, University of Milan, Italy; Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy. Electronic address: spinello.antinori@unimi.it.
² Luigi Sacco Department of Biomedical and Clinical Sciences, University of Milan, Italy; Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.
³ Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.
⁴ Microbiology, Virology and Bioemergence Diagnostics, ASST Fatebenefratelli Sacco, Milan, Italy.
⁵ Rheumatology Unit, ASST Fatebenefratelli Sacco, Milan, Italy.

Comment

Spinello Antinori et al. Autoimmun Rev. 2020 Jul.

. 2020 Jul;19(7):102564.

doi: 10.1016/j.autrev.2020.102564. Epub 2020 May 5.

¹ Luigi Sacco Department of Biomedical and Clinical Sciences, University of Milan, Italy; Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy. Electronic address: spinello.antinori@unimi.it.
² Luigi Sacco Department of Biomedical and Clinical Sciences, University of Milan, Italy; Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.
³ Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.
⁴ Microbiology, Virology and Bioemergence Diagnostics, ASST Fatebenefratelli Sacco, Milan, Italy.
⁵ Rheumatology Unit, ASST Fatebenefratelli Sacco, Milan, Italy.

No abstract available

Comment on

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.
McGonagle D, Sharif K, O'Regan A, Bridgewood C. McGonagle D, et al. Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3. Autoimmun Rev. 2020. PMID: 32251717 Free PMC article. Review.

1. McGonagle D., Sharif K., O’Regan A., Bridgewood C. Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome. Autoimmun Rev. 2020 doi: 10.1016/j.autrev.2020.102537. - DOI - PMC - PubMed
1. Wu C., Chen X., Cai Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 doi: 10.1001/jamainternmed.2020.0994. [March 13] - DOI - PMC - PubMed
1. Mehta P., DF McAuley, Brown M. COVID-19. consider cytokine storm syndromes and immunosuppression. Lancet. 2020 doi: 10.1016/S0140-6736(20)30628-0. [March 13] - DOI - PMC - PubMed
1. Zhang C., Wu Z., Li J.-W., Zhao H., Wang G.-Q. The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105954. - DOI - PMC - PubMed
1. Ogata A., Kato Y., Higa S., Yoshizaki K. IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review. Mod Rheumatol. 2019;29:258–267. - PubMed